ReviewCurrent hematologic malignancy reports2014

Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT).

Ehab Atallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.